IDEAS home Printed from https://ideas.repec.org/p/col/000547/017644.html
   My bibliography  Save this paper

Caracterización de fuentes de información sobre precios, gasto y consumo de medicamentos en algunos países de América Latina

Author

Listed:
  • Sergio Rodrigo Basto Pacheco
  • María Fernanda Fonseca Muñoz
  • Ángela Patricia Acosta Santamaría

Abstract

Este trabajo analiza la calidad de fuentes de información de precio, gasto y consumo de medicamentos en algunos países de América Latina para la utilización en estudios comparativos. En primera instancia, se detectó, a través de una revisión bibliográfica, que la base de datos IMS Health fue la única fuente usada en la región para desarrollo de estudios comparativos entre 2005 y 2015 publicados en revistas indexadas. La base se caracterizó a través de un estudio de caso. Se encontró que recopila datos de precios y volúmenes de venta reportados a través de una encuesta por los mayoristas. Esto hace que para América Latina la fuente sea representativa únicamente para el sector privado y solo entregue datos sobre el consumo de medicamentos ambulatorios. Los aspectos metodológicos asociados al muestreo de la encuesta y la extrapolación de datos no se especificaron en detalle. Fueron seleccionados ocho portales que reportaban precios de medicamentos o compras públicas, los cuales se evaluaron teniendo en cuenta transparencia, ausencia de conflictos de interés, accesibilidad, actualización, acceso a la información de precios y facilidad de uso. Los portales permiten al usuario la detección de conflictos de interés de sus autores y ágil acceso a la información de precios. Se caracterizó la estructura del dato, observando variabilidad en la naturaleza de los precios recolectados y reportados. No obstante, se evidencia que estas fuentes son un insumo válido para el desarrollo de estudios comparativos de precios de medicamentos, siempre y cuando los investigadores consideren aspectos metodológicos que condicionan el alcance de las bases. Por último, fueron caracterizadas tres bases de prescripción de prestadores y aseguradores, cada base responde a atributos específicos de acuerdo a las necesidades de la institución. Por lo tanto, estas fuentes no pueden ser consideradas como insumos útiles en la realización de estudios comparativos. ***** This dissertation aims to analyze the quality information in database of price, pharmaceutical expenditure and drug consumption in selected Latin American countries (drug utilization in cross-national studies). Firstly, it was found through a review that the IMS Health database was a unique source that has been used in Latin American index journals from 2005 to 2015. This source was analyzed through a case study, and we found that this database collected price data and wholesale market data via a survey. The results showed that this survey was only representative of private sector and out-patient consumption. In addition, the sampling and extrapolation methods used are not clearly reported. Secondly, an analysis was performed on medicine price or government purchases websites. All of them were assessed around following criteria for undertaking international price comparisons: author information, accessibility, update (site & price information), accessibility of price information and user-friendliness. The results showed that these websites allow the detecting of conflicts of interests among the authors. Similarly, provide access to medicine price information. The interpretability of the price data for the user was assessed, thereby providing insight into the usefulness of web medicine prices for international price comparisons. However, it is important that the researchers take into account some limitations. Finally, three prescription registers were analyzed from healthcare providers. The results showed that each database establishes some specific criteria but these sources are useless for development in cross-national studies.

Suggested Citation

  • Sergio Rodrigo Basto Pacheco & María Fernanda Fonseca Muñoz & Ángela Patricia Acosta Santamaría, 2017. "Caracterización de fuentes de información sobre precios, gasto y consumo de medicamentos en algunos países de América Latina," Documentos de trabajo 17644, Escuela de Gobierno - Universidad de los Andes.
    • Handle: RePEc:col:000547:017644
    as

    Download full text from publisher

    File URL: https://egob.uniandes.edu.co/images/books/DT/DT-51.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Danzon, Patricia M. & Chao, Li-Wei, 2000. "Cross-national price differences for pharmaceuticals: how large, and why?," Journal of Health Economics, Elsevier, vol. 19(2), pages 159-195, March.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Bardey, David & Harker, Arturo & Zuluaga, Daniela, 2021. "Price cap regulation in the Colombian pharmaceutical market: An impact evaluation," TSE Working Papers 21-1195, Toulouse School of Economics (TSE).
    2. Gianluca Baio & Laura Magazzini & Antonio Nicita & Fabio Pammolli & Massimo Riccaboni, 2003. "Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica - Impatto sull'Industria e Distorsioni nel Funzionamento del Mercato," Working Papers CERM 0-2003, Competitività, Regole, Mercati (CERM).
    3. Bate, Roger & Jin, Ginger Zhe & Mathur, Aparna, 2011. "Does price reveal poor-quality drugs? Evidence from 17 countries," Journal of Health Economics, Elsevier, vol. 30(6), pages 1150-1163.
    4. Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2011. "External referencing and pharmaceutical price negotiation," Health Economics, John Wiley & Sons, Ltd., vol. 20(6), pages 737-756, June.
    5. Cabolis, Christos & Clerides, Sofronis & Ioannou, Ioannis & Senft, Daniel, 2007. "A textbook example of international price discrimination," Economics Letters, Elsevier, vol. 95(1), pages 91-95, April.
    6. Ganslandt, Mattias & Maskus, Keith E., 2004. "Parallel imports and the pricing of pharmaceutical products: evidence from the European Union," Journal of Health Economics, Elsevier, vol. 23(5), pages 1035-1057, September.
    7. Patricia M. Danzon & Eric L. Keuffel, 2014. "Regulation of the Pharmaceutical-Biotechnology Industry," NBER Chapters, in: Economic Regulation and Its Reform: What Have We Learned?, pages 407-484, National Bureau of Economic Research, Inc.
    8. Pierre Dubois & Morten Sæthre, 2020. "On the Effect of Parallel Trade on Manufacturers' and Retailers' Profits in the Pharmaceutical Sector," Econometrica, Econometric Society, vol. 88(6), pages 2503-2545, November.
    9. Kurt Brekke & Dag Dalen & Tor Holmås, 2014. "Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugs," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(9), pages 937-951, December.
    10. Danzon Patricia M. & Ketcham Jonathan D., 2004. "Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand," Forum for Health Economics & Policy, De Gruyter, vol. 7(1), pages 1-56, January.
    11. Joan Costa-i-Font & Alistair McGuire & Nebibe Varol, 2011. "Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition? Evidence from the OECD, 1999-2008," CESifo Working Paper Series 3441, CESifo.
    12. Paraponaris, A. & Verger, P. & Desquins, B. & Villani, P. & Bouvenot, G. & Rochaix, L. & Gourheux, J. C. & Moatti, J. P. AU -, 2004. "Delivering generics without regulatory incentives?: Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names," Health Policy, Elsevier, vol. 70(1), pages 23-32, October.
    13. Katharina Elisabeth Blankart & Tom Stargardt, 2020. "The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany," Health Economics, John Wiley & Sons, Ltd., vol. 29(S1), pages 63-82, October.
    14. Ammas Siraj Mohammed & Nigist Alemayehu Woldekidan & Fuad Adem Mohammed, 2020. "Knowledge, attitude, and practice of pharmacy professionals on generic medicines in Eastern Ethiopia: A cross-sectional study," PLOS ONE, Public Library of Science, vol. 15(7), pages 1-12, July.
    15. Guillaume Gaulier & Séverine Haller, 2000. "The Convergence of Automobile Prices in the European Union: an Empirical Analysis for the Period 1993-1999," Working Papers 2000-14, CEPII research center.
    16. Danzon, Patricia M & Chao, Li-Wei, 2000. "Does Regulation Drive out Competition in Pharmaceutical Markets?," Journal of Law and Economics, University of Chicago Press, vol. 43(2), pages 311-357, October.
    17. Serra-Sastre, Victoria & Bianchi, Simona & Mestre-Ferrandiz, Jorge & O’Neill, Phill, 2021. "Does NICE influence the adoption and uptake of generics in the UK?," LSE Research Online Documents on Economics 113639, London School of Economics and Political Science, LSE Library.
    18. Comisión Nacional de los Mercados y la Competencia (CNMC), 2022. "Estudio sobre el mercado de distribución mayorista de medicamentos," Colección Estudios de Mercado E/CNMC/002/17, Comisión Nacional de los Mercados y la Competencia (CNMC).
    19. Laura Magazzini & Fabio Pammolli & Gianluca Papa & Nicola Carmine Salerno, 2005. "Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN," Working Papers CERM 01-2005, Competitività, Regole, Mercati (CERM).
    20. Thompson, Simon G. & Nixon, Richard M. & Grieve, Richard, 2006. "Addressing the issues that arise in analysing multicentre cost data, with application to a multinational study," Journal of Health Economics, Elsevier, vol. 25(6), pages 1015-1028, November.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:col:000547:017644. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Alejandra Rojas Forero (email available below). General contact details of provider: https://edirc.repec.org/data/egandco.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.